- ►annals.org [PDF] F Grodstein, JAE Manson, MJ Stampfer - Annals of Internal Medicine, 2001 - Am Coll Physicians Background: The Heart and Estrogen/progestin Replacement Study (HERS) was the
first randomized clinical trial of combined hormone therapy and secondary
prevention of coronary events. The trial had overall null results but ... Cited by 312 - Related articles - All 8 versions
- ►unc.edu [PDF] SR Heckbert, RC Kaplan, NS Weiss, BM Psaty, … - Archives of Internal Medicine, 2001 - Am Med Assoc Background The finding from the Heart and Estrogen/Progestin Replacement Study
(HERS) of increased coronary risk restricted to the first year after starting
postmenopausal hormone therapy raises new questions about the role of ... Cited by 77 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org KP Alexander, LK Newby, AS Hellkamp, RA … - Journal of the American College of Cardiology, 2001 - Elsevier The Coumadin Aspirin Reinfarction Study (CARS) database contains information on
HRT use and menopausal status for women with a recent MI. We classified the
1,857 postmenopausal women in CARS as prior/current HRT users if they took ... Cited by 116 - Related articles - BL Direct - All 15 versions
- ►annals.org [PDF] F Grodstein, JAE Manson, GA Colditz, WC … - Annals of Internal Medicine, 2000 - Am Coll Physicians Background: Most primary prevention studies have found that long-term users of
postmenopausal hormone therapy are at lower risk for coronary events, but
numerous questions remain. An ad- verse influence of hormone therapy on ... Cited by 728 - Related articles - BL Direct - All 16 versions
- ►udl.es [PDF] CM Viscoli, LM Brass, WN Kernan, PM Sarrel, … - The New England journal of medicine, 2001 - nejm.highwire.org N Engl J Med, Vol. 345, No. 17 · October 25, 2001 · www.nejm.org · ...
CLINICAL TRIAL OF ESTROGEN-REPLACEMENT THERAPY AFTER ISCHEMIC STROKE ... A
CLINICAL TRIAL OF ESTROGEN-REPLACEMENT THERAPY AFTER ISCHEMIC STROKE Cited by 656 - Related articles - BL Direct - All 12 versions
- ►vcu.edu [PDF] DM Herrington, DM Reboussin, KB Brosnihan, … - New England Journal of Medicine, 2000 - content.nejm.org Results Estrogen and estrogen plus medroxyprogesterone acetate produced
significant reductions in low-density lipoprotein cholesterol levels (9.4
percent and 16.5 percent, respectively) and significant increases in high- ... Cited by 1182 - Related articles - BL Direct - All 12 versions
- ►annals.org [PDF] HN Hodis, WJ Mack, RA Lobo, D Shoupe, A … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Although observational studies suggest that estro- gen replacement
therapy (ERT) reduces cardiovascular morbidity and mortality in postmenopausal
women, use of unopposed ERT for prevention of coronary heart disease in ... Cited by 396 - Related articles - All 8 versions
F Grodstein, MJ Stampfer - Maturitas, 1998 - Elsevier Many epidemiological studies show that women who use estrogen therapy after
menopause have significantly lower rates of heart disease than postmenopausal
women who do not take estrogen. However, few studies have assessed the ... Cited by 49 - Related articles - All 4 versions
- ►ahajournals.org P Angerer, S Stork, W Kothny, P Schmitt, C … - Arteriosclerosis, thrombosis, and vascular biology, 2001 - Am Heart Assoc Abstract—Postmenopausal hormone replacement therapy (HRT) is associated with
low cardiovascular morbidity and mortality in epidemiological studies. Yet, no
randomized trial has examined whether HRT is effective for prevention of ... Cited by 224 - Related articles - BL Direct - All 8 versions
- ►clevelandclinic.org [PDF] D Grady, D Herrington, V Bittner, R … - Jama, 2002 - Am Med Assoc Context The Heart and Estrogen/progestin Replacement Study (HERS) found no
overall reduction in risk of coronary heart disease (CHD) events among
postmenopausal women with CHD. However, in the hormone group, findings did ... Cited by 1087 - Related articles - BL Direct - All 13 versions
